In 2025, Brookfield Asset Management acquired Antylia Scientific, a leading manufacturer of essential laboratory products, to drive operational efficiencies and enhance value in the growing life sciences and environmental sectors.

Target Information

In 2025, Brookfield Asset Management completed the acquisition of Antylia Scientific, a prominent manufacturer specializing in essential laboratory products. Antylia plays a crucial role in the life sciences and environmental sectors by offering high-quality products known for their precision and reliability, which are fundamental to various scientific applications around the world.

The company’s extensive portfolio includes a range of specialty lab products that serve diverse needs, ensuring that laboratories are equipped with the tools necessary for groundbreaking research and testing. Antylia's commitment to quality and innovation positions it as a trusted partner in advancing scientific progress.

Industry Overview

The global life sciences industry has been witnessing significant growth, driven by increased investment in research and development as well as a higher demand for accurate diagnostic tools. As coun